ACM
CLVS

Asymmetry Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Asymmetry Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,008
Closed -$1.15M – 38
2017
Q3 		$1.15M Sell
14,008
-18,377
-57% -$1.46M 1.34% 23
2017
Q2 		$3.03M Buy
32,385
+29,185
+912% +$1.79M 3.6% 14
2017
Q1 		$204K Sell
3,200
-12,632
-80% -$768K 0.28% 27
2016
Q4 		$703K Buy
+15,832
New +$557K 1.31% 19
2015
Q4 		– Sell
-16,458
Closed -$1.51M – 24
2015
Q3 		$1.51M Buy
+16,458
New +$1.42M 3.37% 14

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Asymmetry Capital Management's CLVS Position: Q4 2017 in Review

Asymmetry Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 14,008 shares — an estimated $1.15M sold.

Asymmetry Capital Management first reported a position in CLVS in Q3 2015 and held it in 5 quarters. The position peaked at $3.03M in Q2 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Asymmetry Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Asymmetry Capital Management sold 14,008 Clovis Oncology, Inc. shares in Q4 2017, an estimated $1.15M.
  • Asymmetry Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 5 quarters.
  • Asymmetry Capital Management's Clovis Oncology, Inc. position peaked at $3.03M in Q2 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Asymmetry Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.